¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10
±³À°ÀÏÀÚ : 2023-06-10
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-3010-3130  

À̸ÞÀÏ : plm3010@amc.seoul.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í 1.Àü¹®ÀÇ »çÀüÁ¢¼ö 50,000¿ø ÇöÀåÁ¢¼ö 60,000¿ø2. ÀüÀÓÀÇ, Àü°øÀÇ ¹× °£È£»ç, ±âŸ µî »çÀüÁ¢¼ö 40,000¿ø ÇöÀåÁ¢¼ö 50,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:00~09:25 Refractory chronic cough: Mechanisms and treatment updates ¼Û¿ìÁ¤(¼­¿ï¾Æ»êº´¿ø ¾Ë·¹¸£±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:25~09:50 The optimal treatment of MAC pulmonary disease Á¶°æ¿í(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 09:50~10:15 Beyond inhaler: non-pharmacologic treatment in COPD À̼¼¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:15~10:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:30~10:40 Importance of accurate nodal staging in stage III NSCLC Áö¿øÁØ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 10:40~11:05 Optimal strategy of surgical treatment in stage III NSCLC À±À籤(¼­¿ï¾Æ»êº´¿ø ½ÉÀåÇ÷°üÈäºÎ¿Ü°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:05~11:30 Update of perioperative chemotherapy in stage III NSCLC À±½Å±³(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:30~11:55 Current practice of radiation therapy in stage III NSCLC ½Å¿µ¼·(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

½Ä»ç 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 11:55~13:00 LUNCH ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:00~13:25 Updated IPF guideline and PPF (progressive pulmonary fibrosis : radiologic aspect äÀºÁø(¼­¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:25~13:50 Hopes and concerns about PAH targeted therapy in PH-ILD ÀÌÀç½Â(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 13:50~14:15 Lung transplantation in ILD patients ±èȣö(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

ÈÞ½Ä 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:15~14:30 COFFEE BREAK ()

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:30~14:55 Effect of corticosteroid therapy in severe pneumonia and ARDS ÇãÁø¿ø(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 14:55~15:20 Severe viral pneumonia other than COVID-19 ÃÖ»óÈ£(¼­¿ï¾Æ»êº´¿ø °¨¿°³»°ú)

±³À°½Ã°£ 06¿ù 10ÀÏ µ¿°ü6Ãþ ´ë°­´ç 15:20~15:45 Treatment of moderate to severe ARDS ¾ÈÁöȯ(¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦25Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : Severe and intractable respiratory disease : 2023-06-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2023-06-10
´ÙÀ½±Û 2023³â ¼­¿ï¾Æ»êº´¿ø ³úÁ¹Áß ½ÉÆ÷Áö¾ö From Basic Principles to Advanced Techniques : 2023-06-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 10 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 7 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 10 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 8 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 6 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 5 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 12 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 7 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 8 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 8 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 7 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷